Stay updated on Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.

Latest updates to the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe record history shows a new revision (v3.5.4) superseding the previous one (v3.5.3), indicating a small update to the study page.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe page footer/site build revision was updated from “v3.5.2” to “v3.5.3,” reflecting a backend or interface version change rather than an update to the trial record itself.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check76 days agoChange DetectedThe Record History gained new entries for Contacts/Locations and Study Status, with revision v3.5.0 released on 2026-03-18. The 2025-11-21 entry and revision v3.4.3 were removed.SummaryDifference0.6%

- Check83 days agoChange DetectedA new revision entry, v3.4.3, was added. The previous revision, v3.4.2, was removed.SummaryDifference0.1%

- Check112 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and the government funding lapse notice along with the prior revision entry (v3.4.1) were removed from the visible history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.